Cancer BiologyMolecular OncologyPeer-reviewed
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells
Juhyeon Son, Lily L. Remsing Rix, Bin Fang…·Uwe Rix
This study shows that combining RET and SRC inhibitors enhances anti-cancer effects in RET fusion-positive cancers by suppressing PAK signaling and restoring sensitivity in resistant cells.
DOI 10.1002/1878-0261.70155